KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for BeOne Medicines (ONC) over the last 11 years, with Q1 2025 value amounting to $1.8 million.

  • BeOne Medicines' Change in Acquisitions & Divestments fell 3220.34% to $1.8 million in Q1 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 9833.91%. This contributed to the annual value of $2.7 million for FY2024, which is 9960.56% down from last year.
  • Per BeOne Medicines' latest filing, its Change in Acquisitions & Divestments stood at $1.8 million for Q1 2025, which was down 3220.34% from $2.7 million recorded in Q1 2024.
  • In the past 5 years, BeOne Medicines' Change in Acquisitions & Divestments registered a high of $1.1 billion during Q1 2021, and its lowest value of -$10000.0 during Q4 2021.
  • Over the past 5 years, BeOne Medicines' median Change in Acquisitions & Divestments value was $256.3 million (recorded in 2022), while the average stood at $357.1 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first plummeted by 10000.13% in 2021, then soared by 211230000.0% in 2022.
  • Over the past 5 years, BeOne Medicines' Change in Acquisitions & Divestments (Quarter) stood at -$10000.0 in 2021, then surged by 2112300.0% to $211.2 million in 2022, then tumbled by 49.95% to $105.7 million in 2023, then plummeted by 97.49% to $2.7 million in 2024, then plummeted by 32.2% to $1.8 million in 2025.
  • Its Change in Acquisitions & Divestments was $1.8 million in Q1 2025, compared to $2.7 million in Q1 2024 and $105.7 million in Q4 2023.